Dark

HSDT
Helius Medical Technologies, Inc. Class A Common Stock (DE)
stock NASDAQ

At Close

May 9, 2025 3:55:38 PM EDT

4.22USD-1.860%(-0.08)6,966

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 9, 2025 8:50:30 AM EDT

4.68USD+8.951%(+0.38)248

After-hours

May 8, 2025 4:26:30 PM EDT

4.37USD+1.392%(+0.06)0

OverviewHistoricalExchangesShortsNews

Jan 26, 2022

04:58PM EST Helius Medical Technologies Sees Q4 Revenue $250K-$260K Benzinga

04:30PM EST -- Fourth Quarter 2021 Revenue Projected to Range from $250,000 to $260,000 -- GlobeNewswire Inc

Jan 11, 2022

10:38AM EST 52 Weeks High And Low Article Benzinga

Dec 20, 2021

05:00PM EST Helius Medical Technologies, Inc. Reports Inducement Grants Under GlobeNewswire Inc

Dec 17, 2021

07:09AM EST Helius Medical Technologies Reports Partnership With Medical University Of South Carolina In Pilot Trial On Stroke Benzinga

07:05AM EST -- PoNS to be used in study of cranial-nerve non-invasive neuromodulation and dynamic gait balance in stroke patients -- GlobeNewswire Inc

Dec 14, 2021

07:22AM EST Helius Medical Technologies, Inc. Announces Issuance Of US Patent For Wireless PoNS Benzinga

07:05AM EST Helius Medical Technologies, Inc. Announces Issuance of U.S. GlobeNewswire Inc

Dec 6, 2021

07:05AM EST Helius Medical Technologies, Inc.s Dr. Antonella GlobeNewswire Inc

Nov 15, 2021

11:24AM EST Noble Capital Markets Downgrades Helius Medical Tech to Market Perform Benzinga

11:21AM EST Overview Of Value Stocks In The Healthcare Sector Benzinga

06:50AM EST Helius Medical Technologies, Inc. (Nasdaq: HSDT) (Helius), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff, President and Chief Executive Officer, and Jeffrey S. Mathiesen, Chief Financial Officer, will participate in 1x1 meetings at the 12th Annual Craig-Hallum Alpha Select Conference, being held virtually on Tuesday, November 16, 2021. GlobeNewswire Inc

Nov 12, 2021

04:05PM EST Helius Medical Technologies, Inc. Announces Closing of $11.1 GlobeNewswire Inc

Nov 10, 2021

05:15PM EST Helius Medical Tech Q3 EPS $(2.01) Misses $(1.75) Estimate, Sales $109.00K Beat $80.00K Estimate Benzinga

10:11AM EST Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2% Benzinga

08:39AM EST Helius Medical Technologies Prices Underwritten Public Offering Of ~1.2M Shares At $8/Share Benzinga

08:35AM EST Helius Medical Technologies Announces Pricing Of $9.6 Mln Public Offering Of 1.2 Mln Shares At $8/Shr RTTNews

08:30AM EST Helius Medical Technologies, Inc. (Nasdaq: HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the pricing of an underwritten registered public offering of 1,204,375 shares of its common stock at a price to the public of $8.00 per share. GlobeNewswire Inc

04:09AM EST Earnings Scheduled For November 10, 2021 Benzinga

Nov 9, 2021

06:29PM EST Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering Of Common Stock; No Terms Disclosed Benzinga

Nov 8, 2021

07:14AM EST Helius Medical Technologies Launches Therapeutic Experience Program Benzinga

07:05AM EST -- Multi-center, company-sponsored, open label observational interventional trial to evaluate impact of subjects adherence to PoNS therapy for gait improvement in Multiple Sclerosis --- Program to include 10-12 U.S. Centers of Excellence; enrollment to commence in Q4 2021 -- GlobeNewswire Inc

Nov 4, 2021

07:17AM EDT Helius Medical Technologies, Inc. Receives PoNS Market Authorization In Australia Benzinga

06:55AM EDT Helius Medical Technologies, Inc. Receives PoNS Market GlobeNewswire Inc

Nov 1, 2021

07:05AM EDT Helius Medical Technologies, Inc. (NASDAQ: HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that the Company will release its third quarter 2021 financial results on Wednesday, November 10, 2021, after the market closes. GlobeNewswire Inc

Oct 29, 2021

04:30PM EDT Helius Medical Technologies, Inc. Reports Inducement Grants Under GlobeNewswire Inc

Oct 12, 2021

07:05AM EDT Helius Medical Technologies, Inc. (Nasdaq: HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff, President and Chief Executive Officer, will present at the Dawson James Small Cap Growth Conference as follows: GlobeNewswire Inc

Sep 22, 2021

04:25PM EDT Helius Medical Technologies To Present At Benzinga Healthcare Small Cap Conference Wednesday, Sept. 29 At 1:35 p.m. EDT Benzinga

04:05PM EDT Helius Medical Technologies, Inc. (Nasdaq: HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff, President and Chief Executive Officer, will present at the Benzinga Healthcare Small Cap Conference as follows: GlobeNewswire Inc

Sep 14, 2021

07:10AM EDT Helius Medical Technologies Appoints Paul Buckman To Board RTTNews

07:05AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the appointment of Paul Buckman to its Board of Directors, effective September 10, 2021. Mr. Buckman will serve as Chair of the Companys Audit Committee and as a member of its Compensation and Nominating & Governance Committees. GlobeNewswire Inc

Sep 7, 2021

07:05AM EDT Helius Medical Technologies, Inc. to Present at the H.C. GlobeNewswire Inc

Sep 2, 2021

08:06AM EDT Helius Medical Technologies On Sept 1 Entered Into Purchase Agreement And Registration Rights Agreement With Lincoln Park Capital Fund Benzinga

Aug 25, 2021

07:00AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that it has provided written notice to the Toronto Stock Exchange (the TSX) regarding the voluntary delisting of its Class A common stock from the TSX. GlobeNewswire Inc

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

08:13AM EDT Helius Medical Announces FDA Breakthrough Device Designation For Dynamic Gait And Balance Deficits Following Stroke RTTNews

07:06AM EDT Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation For PoNS Device For Treatment Of Dynamic Gait And Balance Deficits Following A Stroke Benzinga

07:05AM EDT Helius Medical Technologies, Inc. Announces FDA Breakthrough GlobeNewswire Inc

Aug 12, 2021

04:21PM EDT Helius Medical Tech Q2 EPS $(2.58) Misses $(1.53) Estimate, Sales $71.00K Miss $90.00K Estimate Benzinga

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

04:14AM EDT Earnings Scheduled For August 12, 2021 Benzinga

Aug 11, 2021

05:00PM EDT Helius Medical Technologies, Inc. Reports Inducement Grant Under GlobeNewswire Inc

07:05AM EDT Helius Medical Technologies, Inc. Launches New Website for GlobeNewswire Inc

Aug 9, 2021

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Jul 12, 2021

04:07PM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences in July: GlobeNewswire Inc

Jul 8, 2021

07:37AM EDT Helius Medical Technologies Appoints Antonella Favit-Van Pelt As Chief Medical Officer RTTNews

07:32AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the appointment of Antonella Favit-Van Pelt, M.D., Ph.D. to the position of Chief Medical Officer. GlobeNewswire Inc

Jul 7, 2021

05:30PM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced it will participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics, which will be held from July 8-11th in Los Angeles, California. GlobeNewswire Inc

Jun 30, 2021

07:30AM EDT Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that second quarter of fiscal year 2021 financial results will be released after the market closes on Thursday, August 12th. GlobeNewswire Inc

Jun 15, 2021

08:30AM EDT Helius Medical Technologies, Inc. Expands Executive Leadership GlobeNewswire Inc

Jun 8, 2021

04:05PM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM), (Helius or the Company), a neurotech company focused on neurological wellness, today announced its participation in Noble Capital Markets Virtual Road Show Series, presented by Channelchek, which is scheduled for Thursday, June 10, 2021. GlobeNewswire Inc

Jun 2, 2021

07:05AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the appointment of Frederick Fantazzia to the position of Vice President of Sales & Marketing, North America, effective June 1, 2021. GlobeNewswire Inc

May 17, 2021

04:29PM EDT Helius Medical Tech Q1 EPS $(1.65) Up From $(5.38) YoY, Sales $84.00K Down From $207.00K YoY Benzinga

04:05PM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended March31, 2021. GlobeNewswire Inc

04:10AM EDT Earnings Scheduled For May 17, 2021 Benzinga

Apr 15, 2021

08:36AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that management will participate in the Planet MicroCap Showcase, which is being held virtually from April 20th-22nd. Management will present on Wednesday, April 21st at 8:30 a.m. Eastern Time. GlobeNewswire Inc

Apr 7, 2021

04:30PM EDT Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that first quarter of fiscal year 2021 financial results will be released after the market closes on Monday, May 17th. GlobeNewswire Inc

Mar 29, 2021

06:34AM EDT Helius Medical Technologies Receives Marketing Authorization From FDA For PoNS Device RTTNews

06:30AM EDT Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS Device Benzinga

06:30AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that its wholly owned subsidiary, Helius Medical, Inc, has received marketing authorization from the U.S. Food and Drug Administration (FDA) for the Portable Neuromodulation Stimulator (PoNS) device. GlobeNewswire Inc

Mar 26, 2021

11:41AM EDT UPDATE: FDA Says Granted Marketing Authorization Of The Portable Neuromodulation Stimulator To Helius Medical Benzinga

11:41AM EDT Helius Medical Shares Move Higher; FDA Authorizes Marketing Of Device To Improve GAIT In Multiple Sclerosis Patients Benzinga

Mar 24, 2021

11:52AM EDT Noble Capital Markets Initiates Coverage On Helius Medical Tech with Outperform Rating, Announces Price Target of $20 Benzinga

Mar 17, 2021

04:05PM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that management will participate in the Investor Summit Groups Q1 Virtual Summit, which is being held from March 23th-25th. Management will present on Tuesday, March 23th at 2:00 p.m. Eastern Time. GlobeNewswire Inc

07:05AM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the appointment of Sherrie Perkins, effective March 15, 2021. GlobeNewswire Inc

Mar 10, 2021

04:16PM EST Helius Medical Tech Q4 EPS $(1.77) Up From $(6.71) YoY, Sales $191.00K Up From $152.00K YoY Benzinga

04:05PM EST Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today reported financial results for the quarter and full year ended December31, 2020. GlobeNewswire Inc

04:04AM EST Earnings Scheduled For March 10, 2021 Benzinga

Feb 12, 2021

07:54AM EST Helius Medical Technologies Shares Up 33% For Session; Hearing Landenburg Initiates With Buy, Sets $27.50 Price Target Benzinga

Feb 2, 2021

07:30AM EST Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that fourth quarter and fiscal year 2020 financial results will be released after the market closes on Wednesday, March 10th. GlobeNewswire Inc

Feb 1, 2021

05:15PM EST Helius Medical Technologies, Inc. Announces Closing of $11.0 GlobeNewswire Inc

Jan 28, 2021

08:30AM EST Helius Medical Technologies, Inc. Announces Pricing of $9.6 GlobeNewswire Inc

Jan 20, 2021

07:05AM EST Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today provided comments in response to a press release issued by the Centers for Medicare & Medicaid Services (CMS) on Tuesday, January 12, 2021. GlobeNewswire Inc

Jan 19, 2021

07:11AM EST Helius Medical Technologies, Inc. Regains Compliance With Nasdaq Listing Standards Benzinga

07:08AM EST Helius Medical Technologies Regains Compliance With Nasdaq Listing Standards RTTNews

07:05AM EST The Companys Stock Will Continue to be Listed and Traded on The Nasdaq Stock Market GlobeNewswire Inc

Jan 15, 2021

12:37PM EST Helius Medical Technologies, Inc. to Present at GlobeNewswire Inc

Jan 11, 2021

07:13AM EST Helius Submits Response To FDA In Pursuit Of De Novo Classification And Clearance Of PoNS Device RTTNews

07:12AM EST Helius Medical Technologies, Inc. Submits Response To FDA Request For Additional Information In Pursuit Of De Novo Classification And Clearance Of PoNS Device For Treatment Of Gait Deficit Due To Symptoms Of Multiple Sclerosis Benzinga

07:11AM EST Helius Medical Technologies Submits Response to the FDA in Pursuit of De Novo Classification and Clearance of the PoNS Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis Benzinga

07:05AM EST Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that it has submitted its formal response to the U.S. Food and Drug Administrations (the FDA or Agency) request for additional information. GlobeNewswire Inc

Jan 5, 2021

04:09PM EST Helius Medical Technologies Says Is 'not aware of any undisclosed material change in the business, operations or affairs of Helius that would account for the recent increase in trading activity' Benzinga

04:05PM EST Helius Medical Technologies, Inc. Comments on Unusual Market Activity GlobeNewswire Inc

Jan 4, 2021

07:05AM EST Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences in January: GlobeNewswire Inc

Dec 31, 2020

07:10AM EST Helius Medical Reports 1-for-35 Reverse Stock Split Approved, Effective Jan. 4, 2021 Benzinga

07:09AM EST Helius Medical Technologies Announces 1-for-35 Reverse Split Of Class A Common Stock, Par Value $0.001 RTTNews

07:05AM EST Helius Medical Technologies, Inc. Announces Reverse Stock Split GlobeNewswire Inc

Dec 29, 2020

05:03PM EST Helius Medical Technologies 8-K Shows Co. Shareholders Approved Proposal For Reverse Split In Range Of 1-For-5 To 1-For-35 Benzinga

Dec 10, 2020

05:00PM EST Helius Medical Technologies On Dec. 4 Got NASDAQ Notice Indicating Co Not Eligible For Additional 180 Day Extension To Meet Minimum Bid Price Rule Benzinga

Nov 12, 2020

04:25PM EST Helius Medical Tech Q3 EPS $(0.08) Up From $(0.22) YoY, Sales $131.00K Down From $150.00K YoY Benzinga

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

04:18AM EST Earnings Scheduled For November 12, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Nov 5, 2020

Nov 4, 2020

07:10AM EST Helius Medical Technologies, Inc. Announces the Expansion to a Total of 27 Authorized PoNS Treatment Clinic Locations Across Canada Benzinga

07:05AM EST Helius Medical Technologies, Inc. Announces the Expansion to a GlobeNewswire Inc

Nov 2, 2020

05:00PM EST Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that third quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, November 12th. GlobeNewswire Inc

Oct 26, 2020

05:45PM EDT Helius Medical Technologies Announces Closing of $3.4 Million GlobeNewswire Inc

Oct 22, 2020

07:52AM EDT The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat Benzinga

Oct 21, 2020

04:34PM EDT Helius Medical Technologies Announces $3.4 Million Private Placement Benzinga

Oct 19, 2020

05:17PM EDT 10 Stocks Moving In Monday's After Hours Session Benzinga

04:36PM EDT Helius Medical Technologies Receives Request For Additional Information From FDA Related To Co.'s Request For De Novo Classification And Clearance Of The Portable Neuromodulation Stimulator Benzinga

04:32PM EDT Helius Medical Technologies, Inc. Provides Update GlobeNewswire Inc

Oct 14, 2020

07:11AM EDT Helius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple Sclerosis Insights Benzinga

07:09AM EDT Helius Medical Technologies Announces Partnership With Berlin-based Breakthrough Health RTTNews

07:05AM EDT Helius Medical Technologies, Inc. Announces Partnership with GlobeNewswire Inc

Oct 8, 2020

07:30AM EDT Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the formation of a Multiple Sclerosis (MS) Scientific Advisory Board. GlobeNewswire Inc

Sep 8, 2020

07:11AM EDT Helius Medical Technologies, Inc. Announces Publication Of Peer-Reviewed Study In EMJ Radiology Benzinga

07:05AM EDT Helius Medical Technologies, Inc. Announces Publication of GlobeNewswire Inc

Aug 31, 2020

02:00PM EDT Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences in September: GlobeNewswire Inc

Aug 25, 2020

07:16AM EDT Helius Medical Technologies, Inc. Announces Departure of President, Chief Executive Officer and Chairman Philippe Deschamps; Board of Directors Appoints Dane C. Andreeff as Interim President and Chief Executive Officer and Appoints Blane Walter as Chairman of the Board of Directors Benzinga

07:14AM EDT Helius President, CEO And Chairman Philippe Deschamps Deaprts RTTNews

07:05AM EDT Helius Medical Technologies, Inc. Announces Departure of GlobeNewswire Inc

Aug 12, 2020

04:20PM EDT Helius Medical Tech Q2 EPS $(0.08) Down From $(0.01) YoY, Sales $100.00K Down From $518.00K YoY Benzinga

04:21AM EDT Earnings Scheduled For August 12, 2020 Benzinga

Aug 10, 2020

07:05AM EDT Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that second quarter of fiscal year 2020 financial results will be released after the market closes on Wednesday, August 12th. GlobeNewswire Inc

Aug 6, 2020

10:52AM EDT Helius Medical Technologies Sees Q2 Sales $100K Benzinga

10:51AM EDT Helius Medical Technologies, Inc. Submits Request for FDA Clearance for PoNS Device Benzinga

07:05AM EDT Helius Medical Technologies, Inc. Submits Request for FDA GlobeNewswire Inc

Jul 14, 2020

07:10AM EDT Helius Medical Reports Dismissal Of Shareholder Class Action Lawsuit RTTNews

07:05AM EDT Helius Medical Technologies Announces the Dismissal of the GlobeNewswire Inc

.dark-mode .ByJfgN{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .ByJfgN{ color: #333333; background-color: white; border: 2px solid #333333; }HSDTHelius Medical Technologies, Inc. Class A Common Stock (DE)stock NASDAQ

HSDT
Helius Medical Technologies, Inc. Class A Common Stock (DE)
stock NASDAQ